Quick Takeaways
- IAF, LLC filed SCHEDULE 13G/A for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA).
- Disclosed ownership: 4.1%.
- Date of event: 28 Jul 2025.
IAF, LLC - 28 Jul 2025 SCHEDULE 13G/A Report for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA)
- Filing Manager
- IAF, LLC
- Reporting Manager
- IAF, LLC
- Symbol
- ERNA
- Shares outstanding
- 7,701,927 shares
- Disclosed Ownership
- 315,779 shares
- Ownership
- 4.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 18 Aug 2025, 16:05:50 UTC
- Date of event
- 28 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"IAF, LLC disclosed 4.1% ownership in Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA) on 28 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Aug 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| IAF, LLC | 4.1% | 315,779 | 315,779 | 0 | /s/ Edward Bennett | Edward G. R. Bennett, Authorized Person |